Mercury/Thimerosal/Autism
Thimerosal is an organic compound that is 49.6% ethyl mercury by weight. Developed as an antiseptic and antibacterial product, pharmaceutical companies began to use thimerosal in vaccines in the 1930s for the intended purpose of preventing bacterial contamination due to repeated needle punctures into multi-dose vials of vaccine. Below are links to abstracts from over 190 research studies detailing the effects of including thimerosal in vaccines.
Annotated Version of Peer-Reviewed, Published Research Linking Autism, Mercury and Thimerosal
In February 2017, Children’s Health Defense collected 89 peer-reviewed published articles linking autism, mercury and thimerosal. Each of these article abstracts are presented here along with a short annotation in layman terms about what the researchers found and how the findings are linked to autism. The science continues to accumulate that mercury and thimerosal are potent drivers of the autism epidemic. Download PDF (36.4MB)
Also see:
Mercury (all sources) Research
Mercury-Thimerosal-Autism Research – 240+ studies (PDF 21.9MB)
Adams 2007 – Mercury, Lead, and Zinc in Baby Teeth of Children with Autism Versus Controls
Barile 2012 – Thimerosal Exposure in Early Life and Neuropsychological Outcomes 7-10 Years Later
Bernard 2002 – The role of mercury in the pathogenesis of autism
Bernard 2004 – Association Between Thimerosal-Containing Vaccine and Autism
Bernard 2008 – Early Thimerosal Exposure and Neuropsychological Outcomes
Blaxill 2004 – Thimerosal and Autism? A Plausible Hypothesis that Should Not Be Dismissed
Blaylock 2009 – A Possible Central Mechanism In Autism Spectrum Disorders, Part 1
Cave 2008 – The History of Vaccinations in the Light of the Autism Epidemic
Chen 2013 – Effect of Thimerosal on the Neurodevelopment of Premature Rats
Colman 2003 – Mercury in Infants give Vaccines Containing Thimerosal
Desoto 2010 – Sorting Out the Spinning of Autism: Heavy Metals and the Question of Incidence
Dorea 2009 – Neonate Exposure to Thimerosal Mercury from Hepatitis B Vaccines
Dorea 2010 – Infants’ Exposure to Aluminum from Vaccines and Breast Milk During the First 6 Months
Dorea 2014 – Canine Hair as a Model for Tracing Ethylmercury from Thimerosal-containing Vaccines
Dorea 2017 – Abating Mercury Exposure in Young Children Should Include Thimerosal-Free Vaccines
Dorea 2017 – Low-dose Thimerosal in Pediatric Vaccines: Adverse Effects in Perspective
Drum 2009 – Are Toxic Biometals Destroying Your Children’s Future?
Elferink 1998 – The Effect of Thimerosal on Neutrophil Migration
Evans 2000 – Regulation Of Sodium Currents Through Oxidation and Reduction of Thiol Residues
Gadad 2013 – Neuropathology and Animal Models of Autism: Genetic and Environmental Factors
Gallagher 2010 – Hepatitis B Vaccination of Male Neonates and Autism Diagnoses, NHIS 1997-2002
Geier 2003 – An Assessment of the Impact of Thimerosal on Childhood Neurodevelopment Disorders
Geier 2003 – Neurodevelopment Disorders after Thimerosal-containing Vaccines: A Brief Communication
Geier 2015 – Thimerosal: Clinical, epidemiologic and biochemical studies
Geier 2016 – Thimerosal-Preserved Hepatitis B Vaccine and Hyperkinetic Syndrome of Childhood
Gericke 1993 – Thimerosal induced changes of intracellular calcium in human endothelial cells
Havarinasab 2004 – Dose-response study of thimerosal-induced murine systemic autoimmunity
Havarinasab 2005 – Immunosuppressive and autoimmune effects of thimerosal in mice
Havarinasab 2005 – Organic mercury compounds and autoimmunity